293 filings
Page 4 of 15
UPLOAD
i0579 3lydjg
29 Jun 22
Letter from SEC
12:00am
8-K
qjd nnhe9kctufvrne
6 Jun 22
Corporate Presentation June 2022
7:58am
8-K
yvoza sbjd06
16 May 22
Submission of Matters to a Vote of Security Holders
4:25pm
EFFECT
px3yjr eqg
7 Apr 22
Notice of effectiveness
12:15am
8-K
1bm mpiv2wh6fm
30 Mar 22
Entry into a Material Definitive Agreement
8:19am
POS AM
btsa3e t0g8v
28 Mar 22
Prospectus update (post-effective amendment)
5:43pm
POSASR
qroqmx
28 Mar 22
Automatic shelf registration (post-effective amendment)
4:05pm
8-K
j29hr mlfda27h
28 Mar 22
Verastem Oncology Provides Financial Update to Support Development of VS-6766 and Defactinib in RAS Pathway-Driven Tumors
8:03am
8-K
87pzzp2flq6
11 Jan 22
Corporate Presentation January 2022
4:15pm
8-K
m58 yq90oh
26 Oct 21
Verastem Oncology Appoints Michelle Robertson to Board of Directors
8:12am
424B5
mpo tkqsytl26yte
2 Aug 21
Prospectus supplement for primary offering
5:15pm
S-3ASR
ifygwcjzrx50 xd
2 Aug 21
Automatic shelf registration
4:43pm
8-K
fcasjdry ozi7f
24 Jun 21
Verastem Oncology Appoints Paul Bunn, M.D., and Lesley Solomon to Board of Directors
7:41am
S-8
k0uonzurtk
15 Jun 21
Registration of securities for employees
2:32pm
8-K
0oel huxiq1
26 May 21
Regulation FD Disclosure
8:34am